Table 1.
Summary of Recommendations
| Gliomas | Meningiomas | Brain metastases | |
|---|---|---|---|
| Identification of neoplastic tissue including the delineation of tumor extent | AA PET ++ | SSTR PET ++ AA PET + FDG PET − |
MRI method of choice AA PET + FDG PET − |
| Assessment of treatment response | AA PET ++ FLT + |
AA PET (++) SSTR PET n.a. |
AA PET (++) FLT PET (++) |
| Differentiation of treatment-related changes from tumor progression at follow-up | AA PET ++ | SSTR PET (++) | AA PET ++ |
++ high diagnostic accuracy; (++) high diagnostic accuracy, but limited data available; + limited diagnostic accuracy; − not helpful; AA PET = amino acid PET; FDG = [18F]-2-fluoro-2-deoxy-d-glucose PET; FLT = 3’-deoxy-3’-[18F]-fluorothymidine PET; n.a. = data not available; SSTR PET = PET using radiolabeled somatostatin receptor ligands.